Cargando…

Strategies to apply 3Rs in preclinical testing

Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorzalczany, Susana B., Rodriguez Basso, Angeles G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491455/
https://www.ncbi.nlm.nih.gov/pubmed/34609088
http://dx.doi.org/10.1002/prp2.863
_version_ 1784578745702547456
author Gorzalczany, Susana B.
Rodriguez Basso, Angeles G.
author_facet Gorzalczany, Susana B.
Rodriguez Basso, Angeles G.
author_sort Gorzalczany, Susana B.
collection PubMed
description Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the necessity to reduce the number of animals used in experimentation, to guarantee their welfare; resorting to animal models only when strictly necessary. The three Rs (Replacement, Reduction, and Refinement), seek to ensure the rational and respectful use of laboratory animals and maintain an adequate projection in terms of bioethical considerations. This article describes different approaches to apply 3Rs in preclinical experimentation for either research or regulatory purposes.
format Online
Article
Text
id pubmed-8491455
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84914552021-10-08 Strategies to apply 3Rs in preclinical testing Gorzalczany, Susana B. Rodriguez Basso, Angeles G. Pharmacol Res Perspect Research Highlights from South America Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the necessity to reduce the number of animals used in experimentation, to guarantee their welfare; resorting to animal models only when strictly necessary. The three Rs (Replacement, Reduction, and Refinement), seek to ensure the rational and respectful use of laboratory animals and maintain an adequate projection in terms of bioethical considerations. This article describes different approaches to apply 3Rs in preclinical experimentation for either research or regulatory purposes. John Wiley and Sons Inc. 2021-10-05 /pmc/articles/PMC8491455/ /pubmed/34609088 http://dx.doi.org/10.1002/prp2.863 Text en © 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Highlights from South America
Gorzalczany, Susana B.
Rodriguez Basso, Angeles G.
Strategies to apply 3Rs in preclinical testing
title Strategies to apply 3Rs in preclinical testing
title_full Strategies to apply 3Rs in preclinical testing
title_fullStr Strategies to apply 3Rs in preclinical testing
title_full_unstemmed Strategies to apply 3Rs in preclinical testing
title_short Strategies to apply 3Rs in preclinical testing
title_sort strategies to apply 3rs in preclinical testing
topic Research Highlights from South America
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491455/
https://www.ncbi.nlm.nih.gov/pubmed/34609088
http://dx.doi.org/10.1002/prp2.863
work_keys_str_mv AT gorzalczanysusanab strategiestoapply3rsinpreclinicaltesting
AT rodriguezbassoangelesg strategiestoapply3rsinpreclinicaltesting